Formulation and antibacterial profiles of clay–ciprofloxacin composites
Source abstract
Abstract
Abstract The ability of clay minerals to adsorb and desorb drugs, including antibacterial molecules, is an attractive and exciting prospect for healthcare applications. The antibacterial ciprofloxacin was adsorbed onto kaolin, montmorillonite K-10, and Laponite® RD then the subsequent antibacterial activity of the composites formed was confirmed. The effects of time, pH, and CIP concentration were investigated. X-ray diffraction (XRD) and Fourier transform infrared (FTIR) spectroscopy were used to confirm the mechanism of ciprofloxacin adsorption onto the clay minerals. Dispersion pH was the most important variable influencing the adsorption of ciprofloxacin onto the clay minerals and the mechanism of adsorption was confirmed as cation exchange. Adsorption isotherms and application of Langmuir and Freundlich models showed that a ciprofloxacin monolayer was formed at different concentrations on each of the clay minerals tested. Kinetic studies showed that maximal CIP adsorption was achieved within the first hour of adsorption. Antibacterial activity of clay–ciprofloxacin composites against the common skin bacteria Staphylococcus epidermidis and Propionibacterium acnes was demonstrated. This work showed that clay–ciprofloxacin composites are potential delivery systems for ciprofloxacin molecules. As a result, this could make them ideal candidates to take forward for healthcare applications, including the development of novel wound dressings.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Therapeutic Uses of Natural Elements · Clay minerals and soil interactions · Intestinal and Peritoneal Adhesions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Use of clays as drug delivery systems: possibilities and limitations10.1016/j.clay.2006.06.015 ↗
2. Effect of clay–water interactions on clay swelling by X-ray diffraction10.1016/j.nima.2007.05.103 ↗
3. How to select a wound dressing
4. Clay minerals and their beneficial effects upon human health. A review10.1016/S0169-1317(01)00085-0 ↗
5. Adsorption and intercalation of tetracycline by swelling clay minerals10.1016/j.clay.2009.07.002 ↗
6. Adsorption of methylene blue on montmorillonite10.1080/01932699908943843 ↗
7. Tramadol hydrochloride/montmorillonite composite: preparation and controlled drug release10.1016/j.clay.2010.04.011 ↗
8. Clay minerals and layered double hydroxides for novel biological applications10.1016/j.clay.2006.07.007 ↗
9. Layered double hydroxides and human health: an overview10.1016/j.clay.2006.06.010 ↗
10. Bonding mechanisms between aflatoxin B1 and smectite10.1016/j.clay.2010.07.008 ↗
11. Aqueous solubility of ciprofloxacin in the presence of metal cations
12. Sorption of the antimicrobial ciprofloxacin to aluminum and iron hydrous oxides10.1021/es051109f ↗
13. Infections10.1136/bmj.332.7545.838 ↗
14. Adsorption of Pseudomonas putida on clay minerals and iron oxide10.1016/j.colsurfb.2006.10.030 ↗
15. Itraconazole–Laponite: kinetics and mechanism of drug release10.1016/j.clay.2007.09.002 ↗
16. Adsorption and ion exchange: basic principles and their application in food processing10.1021/jf1032203 ↗
17. Stability of bentonites in salt solutions|sodium chloride10.1016/j.clay.2009.04.011 ↗
18. Meticillin resistant Staphylococcus aureus in the hospital10.1136/bmj.b364 ↗
19. Chemically modified smectites10.1180/0009855033810083 ↗
20. Delamination behavior of silicate layers by adsorption of cationic surfactants10.1006/jcis.2002.8222 ↗
21. Interaction between tetracycline and smectite in aqueous solution10.1016/j.jcis.2009.09.054 ↗
22. Mechanism of methylene blue removal from water by swelling clays10.1016/j.cej.2011.02.009 ↗
23. Adsorption of reovirus to clay minerals: effects of cation-exchange capacity, cation saturation, and surface area10.1128/AEM.46.3.673-682.1983 ↗
24. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products10.1016/j.clay.2006.06.016 ↗
25. FTIR techniques in clay mineral studies10.1016/S0924-2031(02)00065-6 ↗
26. The nephelometer: an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines10.1001/jama.1907.25320140022001f ↗
27. Kaolinite properties, structure and influence of metal retention on pH10.1016/S0169-1317(03)00095-4 ↗
28. Traditional and new applications for kaolin, smectite, and palygorskite: a general overview10.1016/S0169-1317(00)00016-8 ↗
29. The rheological properties of dispersions of Laponite, a synthetic hectorite-like clay, in electrolyte solutions10.1180/claymin.1971.009.2.08 ↗
30. The effect of organic cation content on the interlayer spacing, surface area and porosity of methyltributylammonium-smectite10.1016/j.colsurfa.2007.10.029 ↗
31. Laponite-derived porous clay heterostructures: I. Synthesis and physicochemical characterization10.1016/j.micromeso.2009.07.019 ↗
32. Tetracycline adsorption on montmorillonite: pH and ionic strength effects10.1016/j.clay.2007.08.003 ↗
33. Antimicrobial properties of tetracycline and minocycline–montmorillonites10.1016/j.clay.2010.05.005 ↗
34. The loss of antibiotic activity of ciprofloxacin by photodegradation10.1093/jac/26.6.783 ↗
35. Mechanism of adsorption of clindamycin and tetracycline by montmorillonite10.1002/jps.2600670815 ↗
36. Rockwood Additives
37. Interaction of Pseudomonas putida with kaolinite and montmorillonite: a combination study by equilibrium adsorption, ITC, SEM and FTIR10.1016/j.colsurfb.2008.01.008 ↗
38. Antimicrobial prescribing formulary
39. Adsorption of coliphages T1 and T7 to clay minerals10.1128/AEM.43.3.590-596.1982 ↗
40. Novel antibacterial agents for skin and skin structure infections10.1016/j.jaad.2003.10.665 ↗
41. Skin and soft tissue infection diagnosis and management
42. Surface and colloid chemistry of clays10.1021/cr60289a004 ↗
43. Element mobility in clays for healing use10.1016/j.clay.2006.05.011 ↗
44. Skin and soft tissue infections prescribing guidance
45. Spectroscopic investigation of ciprofloxacin speciation at the goethite–water interface10.1021/es061921y ↗
46. Determination of structural modification in acid activated montmorillonite clay by FT-IR spectroscopy10.1016/j.saa.2005.07.018 ↗
47. Clinical pharmacokinetics of ciprofloxacin10.2165/00003088-199019060-00003 ↗
48. Determination by fluorimetric titration of the ionization constants of ciprofloxacin in solution and in the presence of liposomes10.1562/0031-8655(2001)073<0014:DBFTOT>2.0.CO;2 ↗
49. Uses of clay minerals in semisolid health care and therapeutic products10.1016/j.clay.2006.07.006 ↗
50. Cation exchange interaction between antibiotic ciprofloxacin and montmorillonite10.1016/j.jhazmat.2010.07.025 ↗
51. Adsorption of ciprofloxacin on 2:1 dioctahedral clay minerals10.1016/j.clay.2011.06.014 ↗
52. Evaluation of the medicinal use of clay minerals as antibacterial agents10.1080/00206811003679737 ↗
53. Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones10.1086/428053 ↗
54. Adsorption and intercalation of ciprofloxacin on montmorillonite10.1016/j.clay.2010.08.001 ↗
55. Interactions of pathogens Escherichia coli and Streptococcus suis with clay minerals10.1016/j.clay.2012.07.003 ↗